Shenzhen Meili Nanopore Technology Co., Ltd.

       Shenzhen Meili Nanopore Technology Co., Ltd. is a high-tech company based on fourth-generation (nanopore) gene sequencing technology. We develop ultra-long read length, amplification-free, rapid, accurate, and low-cost commercial single-molecule sequencing instruments and supporting reagents. With the mission of "making precision diagnosis accessible to everyone", we open up the full process of sample preparation, library construction, sequencing, bioinformatics analysis, and report generation to form a closed product loop. We continuously lower the usage and price thresholds of products to improve accessibility, promote decentralized deployment of sequencers, and facilitate the popularization of precision medicine. The core technology is based on characteristic current signals generated by the interaction between nanopores and nucleic acid bases, achieving low-cost high-throughput sequencing of nucleic acids at the molecular level through a unique chip system. Our R&D team consists of multiple PhDs from diverse backgrounds including molecular biology, nanotechnology, semiconductors, algorithms, microfluidics, and instrumentation, with over a decade of technical accumulation. After years of R&D, we have obtained over 20 intellectual property rights, broken the monopoly of international giants, and developed domestic sequencer products with a consensus accuracy of 99.999%, reaching the top international level.